| Sound Prosthetics And Orthotics Inc | |
| 530 Lilly Rd Se, Ste 100, Olympia, Washington 98501 | |
| (360) 486-0565 |
| Name | Sound Prosthetics And Orthotics Inc |
|---|---|
| Organization Name | Knapp Prosthetics |
| Location | 530 Lilly Rd Se, Ste 100, Olympia, Washington 98501 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (360) 486-0565 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.
A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.
Exelixis Inc. today announced the initiation of a phase 1 dose-finding trial of cabozantinib in combination with abiraterone in men with metastatic castration-resistant prostate cancer (CRPC) who have disease progression following treatment with up to two prior chemotherapy regimens.
BioMarin Pharmaceutical has announced that the first patient has initiated treatment in the Phase 2a clinical study of 6R-BH4 (sapropterin dihydrochloride) for the treatment of sickle cell disease (SCD).
Children and adolescents with peanut allergies could benefit from treatment with oral immunotherapy (OIT), in which peanut protein is consumed in increasingly larger amounts on a regular basis to build up tolerance, according to a phase 2 trial published in The Lancet.
› Verified 3 days ago
| NPI Number | 1124082433 |
| Organization Name | KNAPP PROSTHETICS |
| Doing Business As | SOUND PROSTHETICS & ORTHOTICS, INC. |
| Type | Prosthetic/Orthotic Supplier |
| Address | 530 Lilly Rd Se, #100, Olympia, WA 98501 |
| Phone Number | 360-486-0565 |
News Archive
Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.
A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.
Exelixis Inc. today announced the initiation of a phase 1 dose-finding trial of cabozantinib in combination with abiraterone in men with metastatic castration-resistant prostate cancer (CRPC) who have disease progression following treatment with up to two prior chemotherapy regimens.
BioMarin Pharmaceutical has announced that the first patient has initiated treatment in the Phase 2a clinical study of 6R-BH4 (sapropterin dihydrochloride) for the treatment of sickle cell disease (SCD).
Children and adolescents with peanut allergies could benefit from treatment with oral immunotherapy (OIT), in which peanut protein is consumed in increasingly larger amounts on a regular basis to build up tolerance, according to a phase 2 trial published in The Lancet.
› Verified 3 days ago
News Archive
Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.
A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.
Exelixis Inc. today announced the initiation of a phase 1 dose-finding trial of cabozantinib in combination with abiraterone in men with metastatic castration-resistant prostate cancer (CRPC) who have disease progression following treatment with up to two prior chemotherapy regimens.
BioMarin Pharmaceutical has announced that the first patient has initiated treatment in the Phase 2a clinical study of 6R-BH4 (sapropterin dihydrochloride) for the treatment of sickle cell disease (SCD).
Children and adolescents with peanut allergies could benefit from treatment with oral immunotherapy (OIT), in which peanut protein is consumed in increasingly larger amounts on a regular basis to build up tolerance, according to a phase 2 trial published in The Lancet.
› Verified 3 days ago
Sav On Pharmacy #3417 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3520 Pacific Ave Se, Olympia, Washington 98501 Phone: (360) 491-9754 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 405 Black Hills Ln Sw, Olympia, Washington 98502 Phone: (360) 352-1753 | |
Custom Care Solutions, Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 530 Lilly Rd Se, Olympia, Washington 98501 Phone: (360) 753-7224 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3508 12th Avenue Ne, Olympia, Washington 98506 Phone: (360) 459-1099 | |
Judys Intimate Apparel Inc Type: Prosthetic/Orthotic Supplier Location: 2528 Pacific Ave Se, Olympia, Washington 98501 Phone: (360) 357-8807 |